Skip to content

Establisment of a Biobank of Esophagus Cancer Organoids and Consistency Evaluation of Organoids with the Parental Tissues

Establisment of a Biobank of Esophagus Cancer Organoids and Consistency Evaluation of Organoids with the Parental Tissues

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063585
Enrollment
Unknown
Registered
2022-09-12
Start date
2022-09-12
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophagus cancer

Interventions

Experiment group:drug sensitiviy assay

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed esophageal cancer, including squamous and adenocarcinoma; 2.Aged = 18 years, including both male and female; 3.Had blood samples as negative control for gene sequencing; 4.Had at least one measurable lesion; 5.Had at least two tumor samples obtained by endoscopic biopsy; 6.Patients voluntary for the study and had written informed consent.

Exclusion criteria

Exclusion criteria: 1.Have serious concurrent illness including but not limited to uncontrolled hypertension, hepatitis B, hepatitis C and HIV infection; 2.Had a history of alcohol or substance abuse; 3.History of other malignancies except esophageal cancer; 4.Others unsuitable for inclusion evaluated by the researchers.

Design outcomes

Primary

MeasureTime frame
Success rate of organoid establishment;Concordance between organoids and the parental tumors;

Secondary

MeasureTime frame
Sensitivity, specificity, and accuracy of drug sensitiviy assay to predict clinical outcome;

Countries

China

Contacts

Public ContactLiu Fang

Chinese PLA General Hospital

Liufangfsq@163.com+86 13520469875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026